Rabeprazole with DomperidoneREVAGO D CAPSULE

Revago D is a fixed-dose combination, indicated primarily for acid-related gastrointestinal disorders and upper GI motility issues. It offers dual action by controlling excess stomach acid and promoting gastric emptying.

• Dosage: Once Daily OR as directed by the Physician
• Form: Capsule
• Indications:
  1. Gastroesophageal Reflux Disease with delayed gastric emptying
  2. Functional dyspepsia
  3. Peptic ulcer disease
  4. Chronic gastritis
  5. Nausea and vomiting associated with acid reflux
  6. Non-ulcer dyspepsia and post-meal fullness
• Composition: Rabeprazole 20mg + Domperidone 30mg
• Mode of Action: Revago D combines rabeprazole, H+/K+ ATPase Inhibitor and Domperidon, a prokinetic agent that works through dual mechanisms to manage acid-peptic disorders, improve gastrointestinal motility and upper GI discomfort unresponsive to monotherapy.
• Packaging:10*10’S
• Therapy Area: Gastroenterology